Drug Profile
Research programme: Hepatitis B vaccine - Haikou VTI Biological Institute
Alternative Names: Therapeutic HBV vaccine - Haikou VTILatest Information Update: 28 Jun 2018
Price :
$50
*
At a glance
- Originator Haikou VTI Biological Institute
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 28 Jun 2018 No recent reports of development identified for research development in Hepatitis-B in China
- 02 May 2014 Early research in Hepatitis B in China (unspecified route) prior to May 2014